amgen.comvsnovartis.com

Amgen edges out Novartis modestly on homepage messaging, 61 to 52. Here's where the gap comes from.

Amgen is clearer about what it does (59 vs 33 on clarity). Amgen has stronger CTAs (75 vs 52). Amgen is better at saying who it's for (ICP: 50 vs 0). Amgen's targeting is decent, while Novartis's is absent. Novartis has a much stronger pricing page (70 vs 0). Amgen doesn't have a detectable pricing page at all.

Both sites use the "Community / Movement" positioning archetype — they're competing on the same narrative, which means differentiation has to come from execution, not framing.